Yifan Pharmaceutical Co., Ltd. (002019.SZ)
CNY 11.38
(0.53%)
CNY 11.38
(0.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.02 Billion | 3.83 Billion | 4.4 Billion | 5.4 Billion | 5.18 Billion | 4.63 Billion |
| Cost of Revenue | 2.19 Billion | 1.97 Billion | 2.58 Billion | 2.89 Billion | 2.79 Billion | 2.59 Billion |
| Gross Profit | 1.83 Billion | 1.86 Billion | 1.82 Billion | 2.5 Billion | 2.39 Billion | 2.04 Billion |
| Operating Expenses | 2.82 Billion | 1.52 Billion | 1.47 Billion | 1.33 Billion | 1.19 Billion | 1.05 Billion |
| Selling, General and Administrative Expenses | 1.49 Billion | 1.17 Billion | 1.03 Billion | 877.19 Million | 798.86 Million | 655.36 Million |
| Research and Development Expenses | 406.94 Million | 190.19 Million | 196.63 Million | 325.34 Million | 208.49 Million | 167.01 Million |
| Other Expenses | 841.45 Million | 161.89 Million | 248.18 Million | 133.05 Million | 190.57 Million | -8.27 Million |
| Cost and Expenses | 4.95 Billion | 3.49 Billion | 4.05 Billion | 4.22 Billion | 3.99 Billion | 3.64 Billion |
| Operating Income | -882.71 Million | 399.37 Million | 348.56 Million | 1.08 Billion | 1.07 Billion | 891.12 Million |
| Interest Expense | 86.45 Million | 85.84 Million | 74.58 Million | 71.06 Million | 70.41 Million | 61.84 Million |
| Income Tax Expense | 16.61 Million | 29.58 Million | -31.42 Million | 149.31 Million | 195.07 Million | 191.23 Million |
| Earnings before Tax | -869.03 Million | 156.73 Million | 210.78 Million | 1.08 Billion | 1.06 Billion | 884.91 Million |
| Net Income | -551.07 Million | 127.15 Million | 278.39 Million | 968.39 Million | 903.46 Million | 737.43 Million |
| Earnings Per Share Basic | -0.45 | 0.11 | 0.23 | 0.80 | 0.75 | 0.61 |
| Earnings Per Share Diluted | -0.45 | 0.10 | 0.23 | 0.79 | 0.74 | 0.61 |
| Weighted Average Shares Outstanding | 1.22 Billion | 1.19 Billion | 1.21 Billion | 1.21 Billion | 1.2 Billion | 1.2 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.22 Billion | 1.27 Billion | 1.21 Billion | 1.22 Billion | 1.22 Billion | 1.2 Billion |
| Gross Margin | 0.46 | 0.49 | 0.41 | 0.46 | 0.46 | 0.44 |
| EBIT Margin | -0.12 | 0.16 | 0.13 | 0.25 | 0.27 | 0.25 |
| Profit Margin | -0.14 | 0.03 | 0.06 | 0.18 | 0.17 | 0.16 |
| EBITDA | -483.52 Million | 471.01 Million | 492.55 Million | 1.34 Billion | 1.3 Billion | 1.06 Billion |
| Earnings Before Tax Margin | -0.22 | 0.10 | 0.08 | 0.20 | 0.21 | 0.19 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.21 Billion | 1.28 Billion | 1.31 Billion | 4.02 Billion | 1.12 Billion | 986.23 Million |
| Cost of Revenue | 645.08 Million | 693.04 Million | 697.9 Million | 2.19 Billion | 689.7 Million | 484.49 Million |
| Gross Profit | 572.69 Million | 593.57 Million | 618.03 Million | 1.83 Billion | 435.89 Million | 501.73 Million |
| Operating Expenses | 507.6 Million | 487.33 Million | 484.74 Million | 1.82 Billion | 1.45 Billion | 438.77 Million |
| Selling, General and Administrative Expenses | 429.89 Million | 430 Million | 420.57 Million | - | 454.46 Million | 505.5 Million |
| Research and Development Expenses | 67.84 Million | 50.79 Million | 59.87 Million | - | 132.01 Million | 66.11 Million |
| Other Expenses | -9.86 Million | -6.53 Million | -4.28 Million | -26.26 Million | -863.96 Million | 8.52 Million |
| Cost and Expenses | 1.15 Billion | 1.18 Billion | 1.18 Billion | 4.01 Billion | 2.14 Billion | 923.26 Million |
| Operating Income | 65.09 Million | 106.24 Million | 133.29 Million | 9.45 Million | -1.01 Billion | 22.53 Million |
| Interest Expense | 19.21 Million | 16.77 Million | 16.66 Million | 75.55 Million | 17.5 Million | 17.22 Million |
| Income Tax Expense | -3.9 Million | 39.83 Million | 41.36 Million | 16.61 Million | -17.04 Million | 14.63 Million |
| Earnings before Tax | 97.86 Million | 145.45 Million | 163.43 Million | -849.79 Million | -998.23 Million | 31.06 Million |
| Net Income | 113.15 Million | 107.12 Million | 146.09 Million | -551.07 Million | -697.91 Million | 38.18 Million |
| Earnings Per Share Basic | 0.09 | 0.09 | 0.12 | - | -0.57 | 0.03 |
| Earnings Per Share Diluted | 0.09 | 0.09 | 0.12 | - | -0.57 | 0.03 |
| Weighted Average Shares Outstanding | 1.21 Billion | 1.22 Billion | 1.21 Billion | 1.21 Billion | 1.22 Billion | 1.21 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.21 Billion | 1.22 Billion | 1.21 Billion | 1.21 Billion | 1.22 Billion | 1.21 Billion |
| Gross Margin | 0.47 | 0.46 | 0.47 | 0.46 | 0.39 | 0.51 |
| EBIT Margin | 0.10 | 0.15 | 0.15 | - | -0.83 | 0.06 |
| Profit Margin | 0.09 | 0.08 | 0.11 | -0.14 | -0.62 | 0.04 |
| EBITDA | 117.07 Million | 193.17 Million | 193.84 Million | - | -938.35 Million | 59.25 Million |
| Earnings Before Tax Margin | 0.05 | 0.08 | 0.10 | 0.00 | -0.90 | 0.02 |
DSV
MNDY
PKP
603963
SHRICON
ORGN